ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
16.31
-0.65 (-3.83%)
At close: Oct 31, 2024, 4:00 PM
18.10
+1.79 (10.97%)
After-hours: Oct 31, 2024, 6:44 PM EDT

ADMA Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
330.24258.22154.0880.9442.2229.35
Upgrade
Revenue Growth (YoY)
58.69%67.59%90.36%91.72%43.85%72.79%
Upgrade
Cost of Revenue
175.84167.17118.8279.7753.7939.5
Upgrade
Gross Profit
154.491.0435.271.17-11.57-10.16
Upgrade
Selling, General & Admin
64.9162.5970.355.1939.2228.08
Upgrade
Research & Development
2.053.33.612.855.912.34
Upgrade
Operating Expenses
67.6666.6174.6358.7545.8431.27
Upgrade
Operating Income
86.7424.43-39.37-57.57-57.41-41.42
Upgrade
Interest Expense
-20.16-25.03-19.28-13.06-11.99-8.99
Upgrade
Interest & Investment Income
1.871.620.050.040.290.8
Upgrade
Other Non Operating Income (Expenses)
-0.3-0.29-0.64-0.25-0.13-0.23
Upgrade
EBT Excluding Unusual Items
68.150.74-59.23-70.85-69.24-49.84
Upgrade
Merger & Restructuring Charges
-----7.5-
Upgrade
Gain (Loss) on Sale of Assets
-----11.53
Upgrade
Asset Writedown
-2.1-2.1----
Upgrade
Other Unusual Items
-26.87-26.87-6.67-0.80.99-9.96
Upgrade
Pretax Income
39.17-28.24-65.9-71.65-75.75-48.28
Upgrade
Income Tax Expense
4.38-----
Upgrade
Net Income
34.79-28.24-65.9-71.65-75.75-48.28
Upgrade
Net Income to Common
34.79-28.24-65.9-71.65-75.75-48.28
Upgrade
Shares Outstanding (Basic)
2282241981408654
Upgrade
Shares Outstanding (Diluted)
2332241981408654
Upgrade
Shares Change (YoY)
10.28%13.19%41.77%62.03%58.51%20.27%
Upgrade
EPS (Basic)
0.15-0.13-0.33-0.51-0.88-0.89
Upgrade
EPS (Diluted)
0.15-0.13-0.33-0.51-0.88-0.89
Upgrade
Free Cash Flow
66.644.03-73.42-125.88-114.73-80.01
Upgrade
Free Cash Flow Per Share
0.290.02-0.37-0.90-1.33-1.47
Upgrade
Gross Margin
46.75%35.26%22.89%1.45%-27.41%-34.60%
Upgrade
Operating Margin
26.27%9.46%-25.55%-71.13%-135.99%-141.14%
Upgrade
Profit Margin
10.53%-10.94%-42.77%-88.52%-179.41%-164.50%
Upgrade
Free Cash Flow Margin
20.18%1.56%-47.65%-155.52%-271.74%-272.60%
Upgrade
EBITDA
95.0932.76-32.25-52.08-53.47-38.17
Upgrade
EBITDA Margin
28.79%12.69%-20.93%-64.34%-126.65%-130.04%
Upgrade
D&A For EBITDA
8.358.327.115.53.943.26
Upgrade
EBIT
86.7424.43-39.37-57.57-57.41-41.42
Upgrade
EBIT Margin
26.27%9.46%-25.55%-71.13%-135.99%-141.14%
Upgrade
Revenue as Reported
----42.2229.35
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.